Amlodipine Besylate
- Product NDC
- 0615-6582
- 11-digit product format
- 006156582
- Labeler code
- 0615
- Product ID
- 0615-6582_789f7015-8b9c-4c80-98ea-71acdf80581c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amlodipine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA076418
- Marketing category
- ANDA
- Marketing start
- 2011-03-11
- Marketing end
- 0000-00-00
- Substance
- AMLODIPINE BESYLATE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-6582-30 | 2021-03-05 | C162847 | 48780-1 | 9d75b9d0-be36-f424-e053-dadaa90a57ce | 3911a46c-80fe-4b70-a4ba-416de597481b |
| 0615-6582-31 | 2021-03-05 | C162847 | 48780-1 | 9d75b9d0-be36-f424-e053-dadaa90a57ce | 3911a46c-80fe-4b70-a4ba-416de597481b |
| 0615-6582-39 | 2021-03-05 | C162847 | 48780-1 | 9d75b9d0-be36-f424-e053-dadaa90a57ce | 3911a46c-80fe-4b70-a4ba-416de597481b |
| 0615-6582-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-be36-f424-e053-dadaa90a57ce | 3911a46c-80fe-4b70-a4ba-416de597481b |
| 0615-6582-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-be36-f424-e053-dadaa90a57ce | 3911a46c-80fe-4b70-a4ba-416de597481b |
| 0615-6582-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-be36-f424-e053-dadaa90a57ce | 3911a46c-80fe-4b70-a4ba-416de597481b |